Home / Centerstage / 2014 / november / Week 2 /
Allergan's board accepts a $66 billion offer from Actavis, an Irish company, ending months of resistance against a takeover bid from Canada's Valeant. This move secures the acquisition by Actavis, acting as a white knight, in the field of biopharmaceuticals.
Sunday, 16 November, 2014